ADD ANI AS A TRUSTED SOURCE
googleads
Menu
Asia

Pakistan power regulatory authority increases electricity tariff by PKR 2.83 per unit

As per the details, the hike in electricity price will apply to electricity bills of May.

ANI May 09, 2024 09:44 IST googleads

Representative Image

Islamabad [Pakistan], May 9 (ANI): The National Electric Power Regulatory Authority (NEPRA) on Wednesday increased the electricity price by Pakistani Rupees (PKR) 2.83 per unit under the monthly fuel adjustment, Pakistan-based ARY News reported.
As per the details, the hike in electricity price will apply to bills of May. However, Life Line and K-Electric consumers have been excluded from the hike. The revised price is expected to place an additional burden of more than PKR 26 billion on consumers.
Pakistan's power regulatory authority's decision comes after K-Electric (KE) on April 29 sought PKR 18.86 per unit hike in power tariff on account of monthly Fuel Charges Adjustments (FCA) of seven months in an application to NEPRA, according to ARY News report.
K-Electric had requested a rise of PKR 18.86 in the power tariff for consumers in Karachi for seven months, from July 2023 to March 2024, according to ARY News report. The NEPRA will hold a hearing on the K-Electric application on May 9.
Earlier in March, the National Electric Power Regulatory Authority (NEPRA) permitted Pakistan's federal government to increase electricity rates by Pakistani Rupees (PKR) 2.75 per unit for all consumers in Pakistan for three months from April to June, with additional revenue effects exceeding PKR 85 billion, Pakistan-based Dawn reported.
The hike in electricity tariff was allowed under quarterly tariff adjustment for the second quarter -- October to December 2023, of the current fiscal year, as per the Dawn report. In the documents released on its website, the authority mentioned that the hike will be applicable to consumers of all categories, except lifeline consumers, including both consumers of ex-Wapda distribution companies and K-Electric.
The authority's decision, announced in a letter, was being sent to the federal government for information and action before its notification by Nepra, Dawn reported. The Nepra claimed that the hike was applied "in the interest of consumers" from April onwards, following the expiry of existing applicable quarterly adjustments in March. (ANI)

Get the App

What to Read Next

Europe

Blasphemy laws in Pakistan target religious minorities: GHRD

Blasphemy laws in Pakistan target religious minorities: GHRD

At the 61st session of the United Nations Human Rights Council, the organisation Global Human Rights Defence (GHRD) raised concerns over the continued misuse of blasphemy laws in Pakistan and their impact on religious minorities.

Read More
Europe

Growing empowerment of women reflects changing social landscape

Growing empowerment of women reflects changing social landscape

In her statement, Bhat said new pathways to empowerment are emerging across the Union Territory, supported by government initiatives and community participation.

Read More
Asia

MEA rejects Pakistan’s statement on India-Canada deal

MEA rejects Pakistan’s statement on India-Canada deal

"We reject this statement made by Pakistan on the matter. India's credentials regarding non-proliferation are impeccable and well recognised by the global community. A country with a well-documented history of clandestine nuclear proliferation can hardly preach the virtues of export controls and proliferation risks. Such ludicrous statements are nothing more than an attempt by Pakistan to distract from its own abysmal record," he said.

Read More
Asia

India rejects Pakistan's "baseless allegations"

India rejects Pakistan's

India on Thursday rejected Pakistan's allegations of aggravating skirmishes with Afghanistan, calling them "baseless" and accusing Pakistan of blaming others for its own misdeeds.

Read More
Asia

Policy delays leave Pakistan short of critical medicines

Policy delays leave Pakistan short of critical medicines

Pakistan faces a severe shortage of life-saving medicines, including cancer drugs and vaccines, due to government delays in notifying official prices. While global supply remains stable, regulatory hurdles have stalled legal imports, raising concerns over patient survival and the potential rise of unregulated, counterfeit medicines.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.